ClinicalTrials.Veeva

Menu

Relationship Between PTEN and Glycemic Variability and Outcome in Critically Ill Patients (GLUPTEN)

U

University of Roma La Sapienza

Status

Completed

Conditions

Hyperglycemia
Critical Illness

Study type

Observational

Funder types

Other

Identifiers

NCT01796847
LAVPTEN

Details and patient eligibility

About

Glycemic variability in critically ill patients is a recognized negative prognostic factor. The molecular mechanisms determining inter-patients variability in glucose metabolism during stress are not fully understood. The Phosphatase and Tensin homolog (PTEN) is known to influence glucose homeostasis by interfering in intracellular insulin signaling.

Aim of this study is to ascertain whether differential expression of PTEN in critically ill patients correlates with glycemic variability and clinical outcome.

Enrollment

20 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • trauma
  • provision informed consent

Exclusion criteria

  • diabetes
  • impaired fasting glucose levels

Trial design

20 participants in 1 patient group

PTEN, hyperglycemia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems